Laurido-Soto, Osvaldo J.
Tan, Gansheng
Nielsen, Susan Searles
Huguenard, Anna L.
Donovan, Kara M.
Xu, Isabella
Giles, James
Dhar, Rajat
Adeoye, Opeolu
Lee, Jin-Moo https://orcid.org/0000-0002-3979-0906
Leuthardt, Eric https://orcid.org/0000-0003-4154-3135
Funding for this research was provided by:
National Institutes of Health (UL1TR002345)
Clinical and Translational Research Funding Program
National Institute of Neurological Disorders and Stroke (K23NS136843)
National Institute of Neurological Disorders and Stroke (R01NS121218)
National Institute of Neurological Disorders and Stroke (R37 NS110699)
Article History
Received: 12 October 2025
Revised: 10 December 2025
Accepted: 12 December 2025
First Online: 22 December 2025
Declarations
:
: This study was conducted in accordance with the Helsinki Declaration and approved by Washington University School of Medicine institutional review board.
: Informed consent was obtained from all individual participants, or their legal guardian.
: EL and ALH report stock ownership in Aurenar. JML, OLS, SSN, JG, RD, and GT do not have related financial disclosures. At no time was this trial funded, designed, nor supported by industry.